-
Birmingham City Seek First Championship Win Against Wrexham
-
Trump announces new US 'Space Academy'
-
Four-wicket Robinson stars as Pakistan collapse in second Test
-
Best Laser Printers in India: Top Options from HP, Brother and Canon
-
Alcaraz anxious after layoff but feels 'great' about wrist
-
US Monroe Doctrine Revival Risks Pushing Latin America Toward China
-
Bezzecchi edges Marquez brothers in blazing Spanish MotoGP practice
-
Former Spain captain Morata joins second-tier Leganes
-
Ukraine opposes reintegration of Russia to motorsport
-
Does the Nepal glacier collapse signal a new climate risk?
-
The chaotic saga of Kanye West's planned Russian concerts
-
Gianni Infantino’s FIFA Presidency Faces Unprecedented Governance Crisis
-
Missing soar over 2,400 after deadly Nepal, China floods
-
SmartMarket Solutions Announces Its BBB Accreditation with an A+ Rating
-
India Orders Wind Turbine Makers to Report on Data Localization for Cybersecurity
-
Greenland to open truth commission over forced contraception scheme
-
Leknessund breaks away to win emotional Vuelta stage seven
-
Stocks, dollar rise after Fed chief lifts rate expectations
-
Four-wicket Robinson stars as Pakistan all out for 110 in second Test
-
'Game-changer': solar ambulance completes test run in Kenya
-
Fed chair Warsh signals 'work to do' on high US inflation
-
Fernandez's Chelsea future uncertain as Alonso seeks commitment
-
Watkins's legacy at Villa untarnished, says Emery as Jackson arrives
-
Four plead guilty to London arson attack on Jewish ambulances
-
Spurs boss De Zerbi targets one more big signing before window shuts
-
Meta's teen safety deal runs into an unsolved problem: proving age
-
Fed chair Warsh flags high US inflation as 'concerning'
-
Windmills of change: Dutch raise mill in rare operation
-
Same Election Question, Two Different Odds: Predictions.io Launches Free Cross-Venue Comparison Tools
-
Netanyahu party in uproar as far-right refuses pleas to unite
-
Man Utd new signing Baleba sidelined for three weeks
-
Stocks advance with all eyes on Fed chair's speech
-
Juve's Yildiz to miss 'several months' with foot injury
-
War criminal Ratko Mladic's death lays bare Bosnia's wounds
-
Celine Dion arrives in France ahead of sold-out comeback dates
-
Thieves buy tickets before plundering necklace from Vienna museum
-
All-round Tongue stars for England in second Test against Pakistan
-
Swiss nuclear plant fully back online after heatwaves
-
UEFA's legal move 'massive escalation' in bitter Infantino feud
-
Bournemouth, Sunderland to face AC Milan in Europa League
-
MEXC Launches Earn Plus With Limited-Time Event Offering Up to 800% APR Booster
-
Once a legend, humpback whales make comeback in Brazil
-
Norway's new King Haakon VIII, popular face of shaken monarchy
-
'Ran for our lives': Tales of survival from Nepal-China disaster
-
Stocks rise ahead of Fed chair's policy speech
-
Bombay High Court Questions Police Probe in Disha Salian Death Case
-
Norway's new King Haakon VII, popular face of shaken monarchy
-
Orthopaedician Dr Akhil Kulshreshtha Shares 5 Tips for Bone and Joint Health
-
Last-wicket duo take England to 290 all out in 2nd Test against Pakistan
-
All eyes on Warsh as Fed chair kicks off key central banking meeting
First no-prescription birth control pill approved in US
US health authorities on Thursday approved the first over-the-counter birth control pill in the country, dramatically widening access to contraception for women in the United States where abortion rights are increasingly under assault.
The medication, Opill, will become available in pharmacies and supermarkets as well as online early next year, the manufacturer Perrigo said in a statement.
More than 100 countries already allow contraceptive pills to be sold over the counter. But in the United States approval comes after the Supreme Court last year scrapped federal abortion protections and the procedure is now banned in several states.
"Today's approval marks the first time a nonprescription daily oral contraceptive will be an available option for millions of people in the United States," said Patrizia Cavazzoni, director of the Food and Drug Administration's Center for Drug Evaluation and Research in a statement.
"When used as directed, daily oral contraception is safe and is expected to be more effective than currently available nonprescription contraceptive methods in preventing unintended pregnancy."
The agency warned, however, that the pill should not be taken by women who have or have ever had breast cancer.
- 'Victory for equity' -
Almost half of the 6.1 million pregnancies in the United States each year are unintended, according to the FDA.
Allowing women to access the progestin-only daily contraceptive pill without needing to see a doctor first "may help reduce the number of unintended pregnancies and their potential negative impacts," the FDA statement said.
The pill, produced by the pharmaceutical company HRA Pharma, which was recently acquired by Perrigo, had already been authorized for prescription in the United States for a number of years.
"This moment is a victory for equity, human rights, public health, and evidence-based research—and especially in light of the ongoing attacks on reproductive health and rights, it is a reason to celebrate," said the Free the Pill coalition, a leading advocacy group.
Experts say the decision could be especially significant for teenage girls who may find it harder to get to the doctor, particularly if they want to do it on their own.
"An over-the-counter birth control pill has the potential to transform the way people access contraception, especially those who face the most barriers in our health care system, including LGBTQIA+ folks, people of color, and those working to make ends meet," said Lin-Fan Wang, a family physician serving the LGBTQ community and a Free the Pill member.
In May, an expert advisory committee convened by the FDA unanimously voted in favor of authorizing the sale of Perrigo without a prescription, judging that the benefits outweighed the risks.
The contraceptive pill, taken daily at the same time, prevents a pregnancy during sexual intercourse.
F.Carias--PC